126 related articles for article (PubMed ID: 19878356)
1. PIM-1 kinase expression in adipocytic neoplasms: diagnostic and biological implications.
Nga ME; Swe NN; Chen KT; Shen L; Lilly MB; Chan SP; Salto-Tellez M; Das K
Int J Exp Pathol; 2010 Feb; 91(1):34-43. PubMed ID: 19878356
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
Thway K; Flora R; Shah C; Olmos D; Fisher C
Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
[TBL] [Abstract][Full Text] [Related]
3. What's new in adipocytic neoplasia?
Thway K
Histopathology; 2022 Jan; 80(1):76-97. PubMed ID: 34958506
[TBL] [Abstract][Full Text] [Related]
4. Development of a monoclonal antibody to the aP2 protein to identify adipocyte precursors in tumours of adipose differentiation.
Joyner CJ; Triffitt J; Puddle B; Athanasou NA
Pathol Res Pract; 1999; 195(7):461-6. PubMed ID: 10448662
[TBL] [Abstract][Full Text] [Related]
5. A contemporary review of myxoid adipocytic tumors.
Creytens D
Semin Diagn Pathol; 2019 Mar; 36(2):129-141. PubMed ID: 30853315
[TBL] [Abstract][Full Text] [Related]
6. Multiexponential T2 relaxometry of benign and malignant adipocytic tumours.
Nikiforaki K; Ioannidis GS; Lagoudaki E; Manikis GH; de Bree E; Karantanas A; Maris TG; Marias K
Eur Radiol Exp; 2020 Aug; 4(1):45. PubMed ID: 32743728
[TBL] [Abstract][Full Text] [Related]
7. [Adipocytic tumors].
Stock N
Ann Pathol; 2015 Jan; 35(1):41-53. PubMed ID: 25533918
[TBL] [Abstract][Full Text] [Related]
8. [Tumors with predominantly adipocytic morphology].
Wardelmann E; Hartmann W
Pathologe; 2019 Jul; 40(4):339-352. PubMed ID: 31240452
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of PIM-1 is a potential biomarker in prostate carcinoma.
Xu Y; Zhang T; Tang H; Zhang S; Liu M; Ren D; Niu Y
J Surg Oncol; 2005 Dec; 92(4):326-30. PubMed ID: 16299799
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical identification of tumours of adipocytic differentiation using an antibody to aP2 protein.
Bennett JH; Shousha S; Puddle B; Athanasou NA
J Clin Pathol; 1995 Oct; 48(10):950-4. PubMed ID: 8537497
[TBL] [Abstract][Full Text] [Related]
11. Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience.
Tanas MR; Rubin BP; Tubbs RR; Billings SD; Downs-Kelly E; Goldblum JR
Arch Pathol Lab Med; 2010 Dec; 134(12):1797-803. PubMed ID: 21128778
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic implications of Ki-67 expression in adipocytes and lipoblasts: an immunohistochemical study.
Wang HJ; Li CY; Wang YK
Int J Clin Exp Pathol; 2014; 7(12):8899-904. PubMed ID: 25674262
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma.
Reiser-Erkan C; Erkan M; Pan Z; Bekasi S; Giese NA; Streit S; Michalski CW; Friess H; Kleeff J
Cancer Biol Ther; 2008 Sep; 7(9):1352-9. PubMed ID: 18708761
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Classic and Molecular Cytogenetic Alterations in Soft-Tissue Sarcomas: Analysis of 46 Tumors With Emphasis on Adipocytic Tumors and Synovial Sarcoma.
Rao UN; Cieply K; Sherer C; Surti U; Gollin SM
Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):168-177. PubMed ID: 26808135
[TBL] [Abstract][Full Text] [Related]
15. Molecular updates in adipocytic neoplasms
Demicco EG
Semin Diagn Pathol; 2019 Mar; 36(2):85-94. PubMed ID: 30857767
[TBL] [Abstract][Full Text] [Related]
16. ERG expression in chondrogenic bone and soft tissue tumours.
Shon W; Folpe AL; Fritchie KJ
J Clin Pathol; 2015 Feb; 68(2):125-9. PubMed ID: 25378537
[TBL] [Abstract][Full Text] [Related]
17. Tumours composed of fat are no longer a simple diagnosis: an overview of fatty tumours with a spindle cell component.
McCarthy AJ; Chetty R
J Clin Pathol; 2018 Jun; 71(6):483-492. PubMed ID: 29358476
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of a serine-threonine kinase proto-oncogene Pim-1 in oral squamous cell carcinoma.
Chiang WF; Yen CY; Lin CN; Liaw GA; Chiu CT; Hsia YJ; Liu SY
Int J Oral Maxillofac Surg; 2006 Aug; 35(8):740-5. PubMed ID: 16546353
[TBL] [Abstract][Full Text] [Related]
19. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
[TBL] [Abstract][Full Text] [Related]
20. Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors.
Kösemehmetoğlu K; Özoğul E; Babaoğlu B; Tezel GG; Gedikoğlu G
Turk Patoloji Derg; 2017; 1(1):192-197. PubMed ID: 28832074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
